Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
Mayo Clinic
Mayo Clinic
University of Chicago
University of Chicago
Montefiore Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center